Invention Grant
- Patent Title: Modified CEA nucleic acid and expression vectors
- Patent Title (中): 修饰的CEA核酸和表达载体
-
Application No.: US12716239Application Date: 2010-03-02
-
Publication No.: US08236776B2Publication Date: 2012-08-07
- Inventor: Mark Parrington , Linong Zhang , Benjamin Rovinski , Linda R. Gritz , Patricia Greenhalgh
- Applicant: Mark Parrington , Linong Zhang , Benjamin Rovinski , Linda R. Gritz , Patricia Greenhalgh
- Applicant Address: CA Toronto, Ontario
- Assignee: Sanofi Pasteur Limited
- Current Assignee: Sanofi Pasteur Limited
- Current Assignee Address: CA Toronto, Ontario
- Agent Patrick J. Halloran; Reza Yacoob
- Main IPC: A61K48/00
- IPC: A61K48/00
Abstract:
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
Public/Granted literature
- US20100285065A1 MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS Public/Granted day:2010-11-11
Information query
